Related Experiment Video
Updated: May 28, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!
Cachexia causes significant lean tissue loss, impacting patient health. While treatments can increase body mass, they carry severe side effects, especially anabolic steroids targeting the androgen receptor.
Area of Science:
- Medical Science
- Metabolic Disorders
- Pharmacology
Background:
- Cachexia involves loss of metabolically active lean tissue, increasing patient morbidity and mortality.
- Impaired strength and functional status are common clinical manifestations of cachexia.
- Existing treatments for cachexia include anabolic and appetite-stimulating agents.
Purpose of the Study:
- To review the efficacy and safety of agents used to treat cachexia.
- To highlight the benefits and drawbacks of therapies targeting lean body mass and appetite.
- To discuss the specific side effects associated with androgen receptor-targeting agents.
Main Methods:
- Literature review of studies on cachexia treatments.
- Analysis of data on body weight and lean body mass changes.
- Examination of reported adverse events from therapeutic interventions.
Main Results:
- Treatments for cachexia can effectively increase body weight and lean body mass.
- Anabolic steroids and testosterone therapies show efficacy but present significant risks.
- Adverse effects include cardiovascular issues, prostate problems, and virilization.
Conclusions:
- While cachexia treatments can improve body composition, their use requires careful consideration of risks.
- Androgen receptor-targeting agents, though effective, are associated with severe side effects.
- Further research into safer and more effective cachexia therapies is warranted.
More Related Videos
08:55The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation